info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Sequelae of poisoning by drugs, medicaments and biological substances

ST19_SEQUEL_POISO_DRUGS_MEDICAM_BIOLO_SUBST

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 T96#
  • Cause of death: ICD-10 T96#

2 out of 7 registries used, show all original rules.

59

4. Check minimum number of events

None

59

5. Include endpoints

None

59

6. Filter based on genotype QC (FinnGen only)

57

Control definitions (FinnGen only)

Control exclude
ST19_SEQUEL_INJURI_POISO_OTHER_CONSE_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T9
Name in latin
Sequelae intoxicationum agentibus psychotropicis, medicamentis et substantiis biologicis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 57 34 23
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 35.82 34.69 37.49

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
59
Matched controls
590
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T96
ICD-10 Finland
Sequelae of poisoning by drugs, medicaments and biological substances
+∞
84.6
59
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
119.3
73.2
43
13
T36
ICD-10 Finland
Poisoning by systemic antibiotics
96.4
68.9
43
16
F32.9
ICD-10 Finland
Depressive episode, unspecified
12.0
20.9
31
50
XF400
NOMESCO Finland
ECG with 12 standard connections
12.1
19.6
26
36
N06AB04
ATC
citalopram; systemic
10.8
19.2
31
55
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
27.9
18.8
26
16
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
11.6
18.0
24
33
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
11.6
18.0
24
33
N05AH04
ATC
quetiapine; oral
9.5
17.3
37
89
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
50.5
15.5
18
5
AA1AD
NOMESCO Finland
CT of head and brain
8.2
15.0
31
70
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
16.5
14.9
25
25
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
98.4
14.3
15
*
N05BA01
ATC
diazepam; systemic, rectal
9.2
14.1
22
36
N05AH03
ATC
olanzapine; systemic
13.9
12.4
22
24
B18.2
ICD-10 Finland
Chronic viral hepatitis C
+∞
11.8
11
*
N06AX11
ATC
mirtazapine; oral
6.5
11.6
38
128
N06AB06
ATC
sertraline; oral
6.9
11.1
23
50
P19
ICPC
Drug abuse
73.8
11.1
12
*
Z72.2
ICD-10 Finland
Drug use
+∞
10.7
10
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
25.6
10.4
14
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.9
10.2
20
41
X58
ICD-10 Finland
Exposure to other specified factors
6.4
10.1
22
50
N05AX12
ATC
aripiprazole; systemic
11.6
10.1
19
23
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
66.3
10.0
11
*
N05AA02
ATC
levomepromazine; systemic
17.7
9.8
15
11
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
+∞
9.6
9
*
P15
ICPC
Chronic alcohol abuse
29.5
9.3
12
5
N05BA04
ATC
oxazepam; oral
5.1
8.8
31
106
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
104.4
8.7
9
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
104.4
8.7
9
*
N05CF01
ATC
zopiclone; oral
4.9
8.5
32
115
N07BB01
ATC
disulfiram; oral
14.7
8.0
13
11
N03AX09
ATC
lamotrigine; oral
10.2
7.7
15
19
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
+∞
7.4
7
*
R40.2
ICD-10 Finland
Coma, unspecified
+∞
7.4
7
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
34.7
7.4
9
*
P18
ICPC
Medication abuse
34.7
7.4
9
*
N03AG01
ATC
valproic acid; systemic, rectal
9.2
7.3
15
21
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.2
7.1
18
46
TKC20
NOMESCO Finland
Catheterisation of bladder
10.7
7.0
13
15
N05BA12
ATC
alprazolam; oral
7.7
6.9
16
27
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
26.0
6.9
9
*
P01
ICPC
Feeling anxious/nervous/tense
4.3
6.8
25
86
N06AX16
ATC
venlafaxine; oral
4.7
6.7
20
58
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
16.8
6.7
10
7
N03AE01
ATC
clonazepam; systemic
11.2
6.7
12
13
TPH04
NOMESCO Finland
Cathetrisation of vein
4.5
6.6
21
64
F10.09
ICD-10 Finland
Alcohol intoxication UNS
77.9
6.6
7
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
77.9
6.6
7
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.4
6.5
14
21
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
30.3
6.4
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
6.4
33
143
N05AX08
ATC
risperidone; systemic
7.4
6.4
15
26
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
+∞
6.4
6
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
+∞
6.4
6
*
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
+∞
6.4
6
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
+∞
6.4
6
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
+∞
6.4
6
*
P01AB01
ATC
metronidazole; oral, rectal
3.8
6.1
31
132
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.9
6.0
26
99

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
33
10.78
16.59
9.2
1.6
—
—
—
0
0
23
37
9.55
15.03
10.1
1.6
—
—
—
0
0
23
38
9.28
14.67
10.2
1.6
—
—
—
0
0
23
38
9.28
14.67
10.3
1.6
—
—
—
0
0
23
38
9.28
14.67
10.1
1.6
—
—
—
0
0
22
37
8.89
13.74
9.0
1.6
—
—
—
0
0
22
27
12.30
11.71
3.0
1.9
1.63
1.68
mmol/l
0.02
17
20
19
20
13.42
10.80
11.4
1.9
—
—
—
0
0
20
32
8.88
9.05
5.9
24.9
0.82
1.06
mmol/l
0.07
15
24
20
33
8.60
8.87
14.8
1.9
—
—
—
0
0
20
34
8.33
8.70
3.7
10.2
104.75
104.59
mmol/l
0.05
20
34
11
5
26.46
8.36
4.5
3.6
—
—
—
0
0
36
149
4.63
7.80
8.8
14.8
0.98
1.26
inr
—
8
43
27
90
4.69
7.76
7.1
4.5
—
—
—
0
0
15
22
8.74
7.08
3.5
12.3
—
—
—
0
0
13
17
9.46
6.54
7.2
31.1
—
—
—
0
0
13
19
8.44
6.14
3.2
14.6
0.62
0.74
%
0.47
13
19
13
19
8.44
6.14
3.2
14.6
3.63
1.54
%
2.53
13
19
13
22
7.25
5.61
3.7
12.1
1.81
1.10
mmol/l
1.18
13
22
33
155
3.56
5.45
4.6
5.1
34.02
37.32
g/l
2.07
28
148
11
17
7.68
5.05
3.5
16.2
90.65
94.36
%
1.16
11
17
9
10
10.36
4.98
2.8
3.0
1.41
1.72
mmol/l
—
9
10
8
7
12.95
4.94
6.6
10.6
0.50
0.58
mmol/l
—
8
7
11
18
7.24
4.87
8.4
42.0
—
—
—
0
0
9
11
9.41
4.75
3.2
2.3
0.60
0.70
%
—
9
11
38
214
3.18
4.36
9.6
5.1
59.06
56.89
%
0.56
38
208
8
10
9.03
4.21
2.9
3.0
3.81
3.91
mmol/l
—
8
10
14
38
4.50
4.15
6.2
2.8
229.38
6339.81
u/l
—
5
16
11
24
5.38
3.98
1.8
1.3
—
—
—
0
0
7
9
8.63
3.67
18.4
10.6
1665.29
1182.11
nmol/l
—
7
9
21
93
2.95
3.56
5.2
3.5
—
—
—
0
0
29
154
2.74
3.50
1.6
1.8
94.37
95.81
pmol/l
0.06
11
85
7
11
7.04
3.28
1.9
2.5
—
—
—
0
0
8
16
5.60
3.17
4.5
5.9
25.13
23.66
mmol/l
—
8
16
7
12
6.45
3.12
5.1
2.8
—
—
—
0
0
20
95
2.67
2.91
8.7
7.9
—
—
—
0
0
0
72
0.00
2.81
0.0
1.2
—
—
—
0
0
5
6
8.95
2.80
2.0
4.8
—
—
—
0
0
6
10
6.53
2.77
3.2
24.9
23.17
23.70
mmol/l
—
6
10
34
214
2.39
2.68
8.4
5.6
—
—
—
0
0
30
184
2.28
2.45
4.0
2.0
—
—
—
0
0
10
35
3.23
2.34
5.4
4.6
—
—
—
0
0
22
120
2.33
2.34
3.2
2.7
—
—
—
0
0
5
9
5.95
2.26
1.4
1.0
—
—
—
0
0
19
99
2.36
2.23
1.7
2.0
0.48
0.85
mg/l
1.95
14
68
18
95
2.29
2.03
3.1
1.5
—
—
—
0
0
43
323
2.22
1.96
7.8
4.1
—
—
—
0
0
14
67
2.43
1.95
1.7
1.5
1125.33
1243.00
nmol/l
—
9
53
6
17
3.80
1.89
1.0
1.2
—
—
—
0
0
21
131
1.94
1.51
7.0
2.8
12.67
39.88
ng/l
0.77
12
73
12
60
2.26
1.51
2.3
1.5
—
—
—
0
0
5
16
3.31
1.47
1.2
1.1
—
—
—
0
0
27
188
1.80
1.36
14.0
7.9
0.00
0.00
e9/l
-0.00
20
145
12
63
2.14
1.34
1.3
2.9
—
—
—
0
0
36
275
1.79
1.32
5.4
2.8
—
—
—
0
0
16
96
1.91
1.26
1.8
1.5
1.27
1.32
mmol/l
0.11
11
85
9
47
2.08
1.08
1.4
1.3
—
—
—
0
0
21
144
1.71
1.07
3.5
1.8
—
—
—
0
0
9
49
1.98
1.04
1.6
2.0
420.22
428.26
nmol/l
—
9
43
9
51
1.90
1.00
1.3
1.9
—
—
—
0
0
10
56
1.95
0.94
1.4
1.4
—
—
—
0
0
13
84
1.70
0.80
2.6
3.4
1.86
21.93
mg/mmol
—
7
48
5
25
2.09
0.74
1.6
1.4
—
—
—
0
0
6
100
0.56
0.70
2.0
2.8
304.17
7628.52
umol/l
—
6
93
5
28
1.86
0.68
1.2
3.0
—
—
—
0
0
12
80
1.63
0.66
2.7
3.0
15.14
108.41
mg/l
—
7
47
0
19
0.00
0.61
0.0
1.1
—
5.05
—
0
11
14
185
0.68
0.54
2.6
2.0
—
—
—
0
0
5
83
0.57
0.50
1.2
1.6
—
—
—
0
0
10
70
1.52
0.45
8.0
2.6
563.50
547.97
mosm/kgh2o
—
10
62
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
4.9
—
31.82
—
0
17
0
18
0.00
0.40
0.0
1.1
—
1.01
—
0
8
9
69
1.36
0.39
1.8
2.3
—
—
—
0
0
17
140
1.30
0.32
8.2
2.5
—
—
—
0
0
16
135
1.25
0.25
3.3
2.0
—
—
—
0
0
14
118
1.24
0.21
3.1
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
6
51
1.20
0.20
1.2
1.4
—
—
—
0
0
13
111
1.22
0.17
5.6
2.7
—
—
—
0
0
7
88
0.77
0.16
1.3
1.3
—
12.26
—
0
26
12
106
1.17
0.11
2.4
2.9
—
—
—
0
0
5
47
1.07
0.09
1.4
1.4
—
—
—
0
0
7
65
1.09
0.08
2.6
3.0
2.41
2.40
mmol/l
—
7
56
15
163
0.89
0.08
1.4
1.7
—
—
—
0
0
16
169
0.93
0.03
2.1
1.6
—
—
—
0
0
14
139
1.01
0.00
2.0
1.4
2.97
2.05
u/ml
—
7
34
46
462
0.98
0.00
4.3
3.5
2.68
2.79
mmol/l
0.33
40
437
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
1.54
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
0.87
—
0
5
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
11.08
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
1.65
—
0
5
5
59
0.83
-0.00
1.4
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
305.50
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
36.03
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: ST19_SEQUEL_POISO_DRUGS_MEDICAM_BIOLO_SUBST – Sequelae of poisoning by drugs, medicaments and biological substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).